Infosys BPM, the business process management arm of Infosys (NSE: INFY) (BSE: INFY) , today announced the launch of AI agents for invoice processing within its flagship Infosys Accounts Payable on ...

Equity Insider News Commentary – With early onset cancer rates on the rise and funding being cut to NIH, the future for cancer patients is increasingly being shaped not by public institutions, but by ...

Pelareorep initiates a pro-inflammatory tumor microenvironment (TME) and induces innate and adaptive immune responses New ...

Geopolitical friction hasn’t slowed outbound moves as Keeta enters Brazil, Huawei bets on ASEAN energy, and robotaxis roll ...

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...

Qatar pushes back on reports of $400M Boeing jet gift to Trump These Frozen Appetizers At Costco Are Better Than Restaurant Made House GOP tax bill calls for ‘SALT’ deduction cap of $30,000 ...

Serial CTRS (CT Response Score) improves prediction of overall survival compared to RECIST 1.1 and Tumor Volume Change in advanced NSCLC CHICAGO--(BUSINESS WIRE)--Onc.AI, a digital health company ...

SAN DIEGO and CALGARY, AB, April 24, 2025 /PRNewswire/ -- Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, will ...

In a report released today, Yaron Werber from TD Cowen maintained a Buy rating on BeiGene (ONC – Research Report), with a price target of $334.00. The company’s shares closed yesterday at $249.13.

A logo is a big part of any major company's brand identity. It takes a lot of work to create a simple little image that the average consumer can immediately associate with certain features and ...